COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 184 filers reported holding COHERUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $810,379 | -77.7% | 216,679 | -74.6% | 0.00% | -100.0% |
| Q2 2023 | $3,640,038 | +243543.8% | 852,468 | +290.2% | 0.00% | +100.0% |
| Q1 2023 | $1,494 | -65.2% | 218,474 | -59.7% | 0.00% | -50.0% |
| Q4 2022 | $4,298 | -99.9% | 542,621 | +4.9% | 0.00% | -33.3% |
| Q3 2022 | $4,970,000 | +76.3% | 517,155 | +32.8% | 0.00% | +50.0% |
| Q2 2022 | $2,819,000 | +8.0% | 389,305 | +92.7% | 0.00% | +100.0% |
| Q1 2022 | $2,609,000 | -50.5% | 202,060 | -38.9% | 0.00% | -66.7% |
| Q4 2021 | $5,274,000 | -32.2% | 330,441 | -31.7% | 0.00% | -40.0% |
| Q3 2021 | $7,778,000 | +126.6% | 484,025 | +95.1% | 0.01% | +150.0% |
| Q2 2021 | $3,432,000 | -41.8% | 248,122 | -38.5% | 0.00% | -50.0% |
| Q1 2021 | $5,894,000 | +2.8% | 403,410 | +14.1% | 0.00% | -69.2% |
| Q1 2020 | $5,733,000 | -50.6% | 353,446 | -45.2% | 0.01% | -13.3% |
| Q4 2019 | $11,603,000 | +671.0% | 644,443 | +767.5% | 0.02% | +650.0% |
| Q3 2019 | $1,505,000 | -61.7% | 74,286 | -58.2% | 0.00% | -66.7% |
| Q2 2019 | $3,928,000 | -61.4% | 177,727 | -76.2% | 0.01% | -60.0% |
| Q1 2019 | $10,180,000 | +19.6% | 746,362 | +44.6% | 0.02% | +50.0% |
| Q3 2018 | $8,515,000 | +0.1% | 516,059 | -15.1% | 0.01% | -9.1% |
| Q2 2018 | $8,509,000 | +383.2% | 607,805 | +281.4% | 0.01% | +450.0% |
| Q1 2018 | $1,761,000 | -71.2% | 159,365 | -77.1% | 0.00% | -75.0% |
| Q4 2017 | $6,119,000 | +324.0% | 695,286 | +543.6% | 0.01% | +300.0% |
| Q3 2017 | $1,443,000 | +53.8% | 108,038 | +65.3% | 0.00% | 0.0% |
| Q2 2017 | $938,000 | -93.6% | 65,345 | -90.6% | 0.00% | -92.6% |
| Q1 2017 | $14,724,000 | -0.7% | 696,149 | +32.2% | 0.03% | -12.9% |
| Q4 2016 | $14,824,000 | -50.4% | 526,600 | -52.8% | 0.03% | -36.7% |
| Q3 2016 | $29,909,000 | +341.7% | 1,116,817 | +178.5% | 0.05% | +206.2% |
| Q2 2016 | $6,772,000 | +452.4% | 400,940 | +555.2% | 0.02% | +700.0% |
| Q3 2015 | $1,226,000 | -69.1% | 61,191 | -55.5% | 0.00% | -75.0% |
| Q2 2015 | $3,972,000 | -53.8% | 137,451 | -51.1% | 0.01% | -50.0% |
| Q1 2015 | $8,593,000 | – | 280,999 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |